Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 578-586

  Kim, Woojun ^a   Lee, Ji Eun ^a   Li, Xue Feng ^a   Kim, Su Hyun ^a   Han, Byeong Gu ^a   Lee, Byung Il ^a   Kim, Jong Kuk ^b   Choi, Kyungho ^a   Kim, Ho Jin ^a  

^a National Cancer Center   (South Korea)

^b Dong A University College of Medicine   (South Korea)

Author keywords

anti aquaporin 4 antibody; aquaporin 4; enzyme linked immunosorbent assay (ELISA); neuromyelitis optica; neuromyelitis optica spectrum disorder

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN ANTIBODY; RECOMBINANT AQUAPORIN 4; RECOMBINANT PROTEIN; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; PROTEIN EXPRESSION; RELAPSE; SENSITIVITY AND SPECIFICITY;

EID: 84860493362     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511424590     Document Type: Article

References (28)

1. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist. 2007 ; 13: 2-11
2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
3. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010 ; 17: 1019-1032
4. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 ; 59: 566-569
5. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 ; 70: 2197-2200
6. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008 ; 131: 3072-3080
7. Weinstock-Guttman B, Miller C, Yeh EA, et al. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Mult Scler. 2008 ; 14: 1061-1067
8. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112
9. Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med. 2006 ; 210: 307-313
10. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007 ; 130: 1235-1243
11. Tanaka Y, Kimura K, Kawachi I, Inuzuka T. No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia. Neurology. 2010 ; 75: 1745-1747
12. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007 ; 130: 1206-1223
13. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007 ; 4: e133
14. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008 ; 65: 913-919
15. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008 ; 196: 181-187
16. Fazio R, Malosio ML, Lampasona V, et al. Antiaquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler. 2009 ; 15: 1153-1163
17. Marnetto F, Hellias B, Granieri L, et al. Western blot analysis for the detection of serum antibodies recognizing linear aquaporin-4 epitopes in patients with neuromyelitis optica. J Neuroimmunol. 2009 ; 217: 74-79
18. Ann Neurol. Polman CH Reingold SC Edan G, ed. 2005: 840-846.
19. Doi T, Hiroaki Y, Arimoto I, et al. Characterization of human endothelin B receptor and mutant receptors expressed in insect cells. Eur J Biochem. 1997 ; 248: 139-148
20. Hiroaki Y, Tani K, Kamegawa A, et al. Implications of the aquaporin-4 structure on array formation and cell adhesion. J Mol Biol. 2006 ; 355: 628-639
21. Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008 ; 5: 22-42
22. Lu M, Lee MD, Smith BL, et al. The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain. Proc Natl Acad Sci U S A. 1996 ; 93: 10908-10912
23. Furman CS, Gorelick-Feldman DA, Davidson KG, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A. 2003 ; 100: 13609-13614
24. Jung JS, Bhat RV, Preston GM, et al. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A. 1994 ; 91: 13052-13056
25. Neely JD, Christensen BM, Nielsen S, Agre P. Heterotetrameric composition of aquaporin-4 water channels. Biochemistry. 1999 ; 38: 11156-11163
26. Mader S, Lutterotti A, Di Pauli F, et al. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One. 2010 ; 5: e10455
27. Tani T, Sakimura K, Tsujita M, et al. Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. J Neuroimmunol. 2009 ; 211: 110-113
28. Leite MI, Waters P, Vincent A. Diagnostic use of autoantibodies in myasthenia gravis. Autoimmunity. 2010 ; 43: 371-379